Wiskott-Aldrich syndrome protein regulates leukocyte-dependent breast cancer metastasis

Cell Reports

Volumn 4, Issue 3, 2013, Pages 429-436

  Ishihara, Dan ^a   Dovas, Athanassios ^a   Hernandez, Lorena ^a   Pozzuto, Maria ^a   Wyckoff, Jeffrey ^a   Segall, JeffreyE ^a   Condeelis, JohnS ^a   Bresnick, AnneR ^a   Cox, Dianne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; WISKOTT ALDRICH SYNDROME PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CARCINOMA CELL; CELL ELONGATION; CELL MOTILITY; CELL SURFACE; COCULTURE; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE MIGRATION; LUNG METASTASIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; TRANSGENIC MOUSE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; TUMOR VOLUME; TUMOR XENOGRAFT;

MUS;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; HETEROGRAFTS; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; RATS; TRIPLE NEGATIVE BREAST NEOPLASMS; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 84881610907     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.07.007     Document Type: Article

References (30)

1. Bañón-Rodríguez I., Monypenny J., Ragazzini C., Franco A., Calle Y., Jones G.E., Antón I.M. The cortactin-binding domain of WIP is essential for podosome formation and extracellular matrix degradation by murine dendritic cells. Eur. J. Cell Biol. 2011, 90:213-223.
2. Chavey C., Bibeau F., Gourgou-Bourgade S., Burlinchon S., Boissière F., Laune D., Roques S., Lazennec G. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res. 2007, 9:R15.
3. DeNardo D.G., Barreto J.B., Andreu P., Vasquez L., Tawfik D., Kolhatkar N., Coussens L.M. CD4(+) Tcells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009, 16:91-102.
4. Dovas A., Gevrey J.C., Grossi A., Park H., Abou-Kheir W., Cox D. Regulation of podosome dynamics by WASp phosphorylation: implication in matrix degradation and chemotaxis in macrophages. J.Cell Sci. 2009, 122:3873-3882.
5. Gay L.J., Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat. Rev. Cancer 2011, 11:123-134.
6. Goswami S., Sahai E., Wyckoff J.B., Cammer M., Cox D., Pixley F.J., Stanley E.R., Segall J.E., Condeelis J.S. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 2005, 65:5278-5283.
7. Hanahan D., Coussens L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21:309-322.
8. Hernandez L., Smirnova T., Kedrin D., Wyckoff J., Zhu L., Stanley E.R., Cox D., Muller W.J., Pollard J.W., Van Rooijen N., Segall J.E. The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12. Cancer Res. 2009, 69:3221-3227.
9. Hume D.A., MacDonald K.P. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2012, 119:1810-1820.
10. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
11. Leek R.D., Hunt N.C., Landers R.J., Lewis C.E., Royds J.A., Harris A.L. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J.Pathol. 2000, 190:430-436.
12. Leuschner F., Dutta P., Gorbatov R., Novobrantseva T.I., Donahoe J.S., Courties G., Lee K.M., Kim J.I., Markmann J.F., Marinelli B., et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat. Biotechnol. 2011, 29:1005-1010.
13. Lin E.Y., Nguyen A.V., Russell R.G., Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J.Exp. Med. 2001, 193:727-740.
14. Lin E.Y., Jones J.G., Li P., Zhu L., Whitney K.D., Muller W.J., Pollard J.W. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 2003, 163:2113-2126.
15. Ojalvo L.S., Whittaker C.A., Condeelis J.S., Pollard J.W. Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J.Immunol. 2010, 184:702-712.
16. Patsialou A., Wyckoff J., Wang Y., Goswami S., Stanley E.R., Condeelis J.S. Invasion of human breast cancer cells invivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res. 2009, 69:9498-9506.
17. Patsialou A., Wang Y., Lin J., Whitney K., Goswami S., Kenny P.A., Condeelis J.S. Selective gene-expression profiling of migratory tumor cells invivo predicts clinical outcome in breast cancer patients. Breast Cancer Res. 2012, 14:R139.
18. Poincloux R., Lizárraga F., Chavrier P. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J.Cell Sci. 2009, 122:3015-3024.
19. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
20. Roussos E.T., Balsamo M., Alford S.K., Wyckoff J.B., Gligorijevic B., Wang Y., Pozzuto M., Stobezki R., Goswami S., Segall J.E., et al. Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer. J.Cell Sci. 2011, 124:2120-2131.
21. Sahin U., Weskamp G., Zheng Y., Chesneau V., Horiuchi K., Blobel C.P. A sensitive method to monitor ectodomain shedding of ligandsof the epidermal growth factor receptor. Methods Mol. Biol. 2006, 327:99-113.
22. Sharma V.P., Beaty B.T., Patsialou A., Liu H., Clarke M., Cox D., Condeelis J.S., Eddy R.J. Reconstitution of invivo macrophage-tumor cell pairing and streaming motility on one-dimensional micro-patterned substrates. IntraVital 2012, 1:77-85.
23. Takenawa T., Suetsugu S. The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat. Rev. Mol. Cell Biol. 2007, 8:37-48.
24. Thrasher A.J., Burns S.O. WASP: a key immunological multitasker. Nat. Rev. Immunol. 2010, 10:182-192.
25. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
26. Wyckoff J.B., Segall J.E., Condeelis J.S. The collection of the motile population of cells from a living tumor. Cancer Res. 2000, 60:5401-5404.
27. Wyckoff J., Wang W., Lin E.Y., Wang Y., Pixley F., Stanley E.R., Graf T., Pollard J.W., Segall J., Condeelis J. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 2004, 64:7022-7029.
28. Wyckoff J.B., Wang Y., Lin E.Y., Li J.F., Goswami S., Stanley E.R., Segall J.E., Pollard J.W., Condeelis J. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 2007, 67:2649-2656.
29. Yao F., Svensjö T., Winkler T., Lu M., Eriksson C., Eriksson E. Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum. Gene Ther. 1998, 9:1939-1950.
30. Zicha D., Allen W.E., Brickell P.M., Kinnon C., Dunn G.A., Jones G.E., Thrasher A.J. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br. J. Haematol. 1998, 101:659-665.